Partnerships in Clinical Trials Asia Pacific Who Attends

	Attendees by Industry

60%	Pharmaceutical, Biotech and Medical Device Companies
25%	CROs, Central, Core, ECG and Imaging Laboratories
5%	Regional Sites and Medical Facilities
5%	Regulatory/Government KOLs
5%	Other Clinical Trials Solution Providers including Biorepositories, Data Management Companies, EDC and other IT Systems providers

	Attendees by Title

40%	VPs and Directors of Global Outsourcing & Procurement
30%	VPs and Directors of Global Clinical Operations & Development
10%	Medical Directors & Clinical Trials Managers
10%	Directors of Contracting, Budgeting and Forecasting
5%	Managers of Vendor Quality, Project Management, Drug Safety and Data Management
5%	Other

	Over 20 countries Represented

50%	North Asia (China, Japan, Taiwan, Korea, Vietnam)
20%	South East Asia (Singapore, Malaysia, Indonesia, Thailand)
10%	Europe
10%	United States
5%	Australia and Pacific
5%	Indian Sub-continent